Location History:
- Seoul, KR (2009 - 2013)
- Nowon-gu, KR (2012 - 2013)
Company Filing History:
Years Active: 2009-2013
Title: Ghilsoo Nam: Innovator in Calcium Channel Modulation
Introduction
Ghilsoo Nam is a prominent inventor based in Nowon-gu, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate calcium channels. With a total of 4 patents to his name, Nam's work is paving the way for new therapeutic approaches.
Latest Patents
Nam's latest patents include innovative compounds that have potential applications in treating various diseases. One of his notable inventions is the "Imidazolylalkylcarbonyl derivatives as calcium channel modulators and preparation method thereof." This patent discloses novel imidazolylalkylcarbonyl derivatives that serve as calcium channel modulators, along with a method for their preparation. Additionally, it outlines a treatment method for diseases by administering these compounds based on their inhibitory activity against calcium channels. Another significant patent is for "1,6-disubstituted-3-amino-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-C]pyridin-7-one compounds and preparation thereof." This invention provides a novel compound and its pharmaceutically acceptable salt, along with a method for its preparation and an anticancer pharmaceutical composition that includes the compound as an effective ingredient.
Career Highlights
Ghilsoo Nam is affiliated with the Korea Institute of Science and Technology, where he conducts his research and development activities. His work has garnered attention for its potential impact on medical treatments and drug development.
Collaborations
Nam collaborates with esteemed colleagues, including Ae Nim Pae and Hyewhon Rhim, who contribute to his research endeavors and enhance the scope of his projects.
Conclusion
Ghilsoo Nam's innovative work in calcium channel modulation and his contributions to medicinal chemistry highlight his role as a leading inventor in the field. His patents reflect a commitment to advancing medical science and improving therapeutic options for patients.